Sentinel lymph node biopsy for melanoma of the head and neck

Expert Review of Anticancer Therapy

Volumn 3, Issue 5, 2003, Pages 673-683

  Lentsch, Eric J ^a   McMasters, Kelly M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Head and neck; Melanoma; Sentinel lymph node biopsy

Indexed keywords

ALPHA2B INTERFERON; GANGLIOSIDE GM2 VACCINE; TUMOR VACCINE; UNCLASSIFIED DRUG;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL STUDY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG MEGADOSE; FACIAL NERVE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; MELANOMA; PAROTID GLAND; PROGNOSIS; RELIABILITY; REVIEW; RISK ASSESSMENT; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

EID: 0242382583     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.3.5.673     Document Type: Review

References (50)

1. Laennec RTH. Sur les melanoses. Bull. Soc. Med. Paris 1, 1-24 (1806).
2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J. Clin. 53(1), 5-26 (2003).
3. Goldsmith HS. Melanoma: an overview. Cancer 29, 194-197 (1979).
4. Batsakis JG. Tumors of the Head and Neck. Clinical and Pathological Considerations, 2nd edition. Williams & Wilkins, Baltimore, USA (1979).
5. Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA. Who discovers melanoma? Patterns from a population-based survey. J. Am. Acad. Dermatol. 26, 914-919 (1992).
6. Morton Dl, Giuliano AE, Reintgen DS, Roses DF, Ross MI, Thompson JF. Symposium: lymphatic mapping and sentinel node biopsy in patients with breast cancer and melanoma, part 2. Contemp. Surg. 53, 353-358 (1998).
7. Balch CM, Buzaid AC, Soong SJ et al. Final version of the AJCC staging system for cutaneous melanoma. J. Clin. Oncol. 19, 3635-3648(2001).
8. Balch CM, Urist MM, Karakousis CP et al. Efficacy of 2-cm surgical margins for intermediate thickness melanomas (1-4 mm). Ann. Surg. 218, 262-269 (1993).
9. Veronesi U, Cascinelli N, Adamus J et al. Thin Stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N. Engl. J. Med. 318, 1159-1162 (1988).
10. Balch CM, Soong SJ, Smith T et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann. Surg. Oncol. 8(2), 101-108 (2001).
11. Zitelli JA, Moy RL, Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J. Am. Acad. Dermatol. 24, 102-106 (1991).
12. Byers RM. The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck. Arch. Surg. 121, 1338-1341 (1986).
13. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of Stage I malignant melanoma: a prospective randomized study. Mayo. Clin. Proc. 61(9), 697-705 (1986).
14. Veronesi U, Adamus J, Bandiera DC et al. Delayed regional lymph node dissection in Stage I melanoma of the skin of the lower extremities. Cancer 49(11), 2420-2430 (1982).
15. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351(9105), 793-796 (1998).
16. Balch CM, Soong SJ, Bartolucci AA et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann. Surg. 224(3), 255-263 (1996).
17. McMasters KM, Reintgen DS, Ross MI et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J. Clin. Oncol. 19(11), 2851-2855 (2001).
18. Balch CM, Soong S, Ross MI et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Ann. Surg. Oncol. 7(2), 87-97 (2000).
19. Essner R, Conforti A, Kelley MC et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann. Surg. Oncol. 6(5), 442-449 (1999).
20. Dessureault S, Soong SJ, Ross MI et al. Improved staging of node-negative patients with intermediate to thick melanomas (> 1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann. Surg. Oncol. 8(10), 766-770 (2001).
21. Goepfert H, Jesse RH, Ballantyne AJ. Posterolateral neck dissection. Arch. Otolaryngol. 106, 618-620 (1980).
22. Norman J, Wells K, Kearney R, Cruse CW, Berman C, Reintgen D. Identification of lymphatic drainage basins in patients with cutaneous melanoma. Semin. Surg. Oncol. 9(3), 224-227 (1993).
23. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J. Clin. Oncol. 11 (9), 1751-1756 (1993).
24. Gershenwald JE, Thompson W, Mansfield PF et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 Stage I or II melanoma patients. J. Clin. Oncol. 17, 976-983 (1999).
25. Gershenwald JE, Colome MI, Lee JE et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with Stage I or II melanoma. J. Clin. Oncol. 16, 2253-2260 (1998).
26. Wells KE, Rapaport DP, Cruse CW et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plast. Reconstr. Surg. 100, 591-594 (1997).
27. Alex JC, Krag DN, Harlow SP et al. Localization of regional lymph nodes in melanomas of the head and neck. Arch. Otolaryngol. Head Neck Surg. 124, 135-140 (1998).
28. O'Brien CJ, Uren RF, Thompson JF et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am. J. Surg. 170, 461-466 (1995).
29. Bostick P, Essner R, Sarantou T. et al. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. Am. J. Surg. 174, 536-539 (1995).
30. Wagner JD, Park HM, Coleman JJ III et al. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch. Otolaryngol. Head Neck Surg. 126(3), 313-321 (2000).
31. Eicher SA, Clayman GL, Myers JN, Gillenwater AM. A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma. Arch. Otolaryngol. Head Neck Surg. 128(3), 241-246 (2002).
32. Patel SG, Coit DG, Shaha AR et al. Sentinel lymph node biopsy for cutaneous head and neck melanomas. Arch. Otolaryngol. Head Neck Surg. 128(3), 285-291 (2002).
33. Schmalbach CE, Nussenbaum B, Rees RS, Schwartz J, Johnson TM, Bradford CR. Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. Arch. Otolaryngol. Head Neck Surg. 129(1), 61-65 (2003).
34. Chao C, Wong SL, Edwards MJ et al. Sunbelt Melanoma Trial Group. Sentinel lymph node biopsy for head and neck melanomas. Ann. Surg. Oncol. 10(1), 21-26 (2003).
35. Wells KE, Cruse CW, Daniels S, Berman CG, Norman J, Reintgen DS. The use of lymphoscintigraphy in melanoma of the head and neck. Plast. Reconstr. Surg. 93, 757-761 (1994).
36. Shah JP, Kraus DH, Dubner S, Sarkar S. Patterns of regional lymph node metastases from cutaneous melanoma of the head and neck. Am. J. Surg. 162, 320-323 (1991).
37. Wenzel S, Metternich FU, Sagowski C, Neuber K, Kehrl W. Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance? Laryngorhinootologie 80, 313-317 (2001).
38. Gershenwald JE, Tseng CH, Thompson W et al. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery 124(2), 203-210 (1998).
39. Albertini JJ, Cruse CW, Rapaport D et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann. Surg. 223(2), 217-224 (1996).
40. Ang KK, Byers RM, Peters LJ et al. Regional radiotherapy as adjuvant treatment for head and neck melanoma. Preliminary results. Arch. Otolaryngol. Head Neck Surg. 116, 169-172 (1990).
41. Ang KK, Peters LH, Weber RS et al. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int. J. Radiat. Oncol. Biol. Phys. 30, 795-798 (1994).
42. 2b adjuvant therapy of high risk resected cutaneous melanoma: the Eastern Co-operative Oncology Group Trial EST 1684. J. Clin. Oncol. 14, 7-17 (1996).
43. 2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J. Clin. Oncol. 18, 2444-2458 (2000).
44. 2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Co-operative Group. J. Clin. Oncol. 15, 2579-2588 (1997).
45. 2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected Stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J. Clin. Oncol. 19(9), 2370-2380 (2001).
46. 2b. J. Clin. Oncol. 17, 968-975 (1999).
47. Wells KE, Stadelmann WK, Rapaport DP et al. Parotid selective lymphadenectomy in malignant melanoma. Ann. Plast. Surg. 43, 1-6 (1999).
48. Jansen L, Koops HS, Nieweg OE et al. Sentinel node biopsy for melanoma in the head and neck region. Head Neck 22(1), 27-33 (2000).
49. Carlson GW, Murray DR, Greenlee R et al. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch. Otolaryngol. Head Neck Surg. 126, 433-437 (2000).
50. Maffioli L, Belli F, Gallino G et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck. Tumori 86, 341-342 (2000).